Estrogen and thyroid cancer is a stem affair: A preliminary study

Area of Science:

• Endocrinology
• Oncology
• Cancer Stem Cell Biology

Background:

• Papillary thyroid cancer (PTC) incidence is significantly higher in women (3:1 ratio) compared to men, suggesting a role for sex hormones.
• Estrogens are implicated in promoting stem cell self-renewal, a key factor in tumor initiation and progression.

Purpose of the Study:

• To investigate the role of estrogens in papillary thyroid cancer (PTC) development and progression.
• To explore the specific mechanisms by which estrogens influence cancer stem cells (CSCs) in PTC.
• To understand the gender-based differences in PTC response to estrogen signaling.

Main Methods:

• In vitro studies exposing PTC stem cells to estradiol to assess effects on growth, self-renewal, proliferation, and differentiation.
• In vivo studies using mouse models inoculated with estradiol-treated or untreated thyroid cancer stem cell-enriched cells.
• Analysis of gender-specific biological response pathways to estrogen in PTC.

Main Results:

• Estradiol exposure promoted PTC stem cell growth, maintenance, proliferation, and differentiation in vitro.
• Continuous estradiol treatment enhanced CSC motility and tumorigenicity in vivo, leading to larger tumors and distant metastasis.
• Mimicking hormonal imbalance yielded opposite phenotypic effects compared to continuous estradiol exposure.
• Estrogen-mediated biological responses in PTC differed between women and men.

Conclusions:

• Estrogens play a crucial role in promoting the growth, stemness, and metastatic potential of papillary thyroid cancer.
• The distinct biological responses to estrogens in women versus men may explain the observed gender disparity in PTC incidence and aggressiveness.
• These findings suggest the potential for developing gender-specific therapeutic strategies for papillary thyroid cancer.